L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
Clinical trial NCT03982160 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03982160
- Sponsor
- The University of Texas at Arlington
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2026-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.